ARCHIVES

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 40 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Panel to Hear Innovation Reports

August 26, 1988

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

Also NY State Initiatives Would Fund Research Using I-ELCAP Protocol for CT Scanning for Lung Cancer.

May 4, 2007